Showing results (1-10 of 570) with videos related to

Sort By:
Pageof 57
Diabetes, Obesity & Metabolism|June 20, 2008
Current treatment of non-alcoholic fatty liver diseaseMohamed H Ahmed, Christopher D Byrne
Drug Discovery Today|September 11, 2007
Modulation of sterol regulatory element binding proteins (SREBPs) as potential treatments for non-alcoholic fatty liver disease (NAFLD)Mohamed H Ahmed, Christopher D Byrne
World Journal of Gastroenterology|September 7, 2010
Obstructive sleep apnea syndrome and fatty liver: association or causal link?Mohamed-H Ahmed, Christopher-D Byrne
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 23, 2010
Bariatric surgery and renal function: a precarious balance between benefit and harmMohamed H Ahmed, Christopher D Byrne
Drug Discovery Today|July 6, 2010
Ezetimibe as a potential treatment for non-alcoholic fatty liver disease: is the intestine a modulator of hepatic insulin sensitivity and hepatic fat accumulation?Mohamed H Ahmed, Christopher D Byrne
Primary Care Diabetes|March 20, 2010
Non-Alcoholic Fatty Liver Disease (NAFLD): new challenge for general practitioners and important burden for health authorities?Mohamed H Ahmed, Emmanuel O Abu, Christopher D Byrne
Clinical Science (London, England : 1979)|February 27, 2009
Metabolic disturbances in non-alcoholic fatty liver diseaseChristopher D Byrne, Rasaq Olufadi, Kimberley D Bruce, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|July 5, 2022
Banting memorial lecture 2022: 'Type 2 diabetes and nonalcoholic fatty liver disease: Partners in crime'Christopher D Byrne
The Proceedings of the Nutrition Society|May 15, 2013
Ectopic fat, insulin resistance and non-alcoholic fatty liver diseaseChristopher D Byrne
Clinical Science (London, England : 1979)|November 11, 2009
Hypoxia and non-alcoholic fatty liver diseaseChristopher D Byrne
Pageof 57